FDAnews Device Daily Bulletin
March 2, 2005 | Vol. 2 No. 43
Cardiac Science, a maker of automatic public-access defibrillators, has agreed to merge with Quinton Cardiology Systems, a Bothell, Wash.-based maker of cardiovascular monitoring products.
Royal Philips Electronics has announced FDA clearance for its HeartStart FRx Defibrillator that is designed for reliability, exceptional ruggedness and ease of use.
VIASYS Healthcare has acquired the global medical division of Oxford Instruments Medical, based in Old Woking, UK, for approximately $46 million.
Genetronics Biomedical, a late-stage developer of oncology and other therapies using electroporation to deliver drugs and nucleic acids, has initiated a Phase I clinical trial to treat pancreatic cancer using its MedPulser Tumor Ablation System.
CSMG Technologies announced that it has received
notice from the U.S. Patent and Trademark Office that its U.S. Application No.
10/310,203 has been allowed for "Bonding of Soft Biological Tissues by
Passing High Frequency Electric Current Therethrough" (Method Divisional
of U.S. patent number 09/022,869) for the company's live-biological-tissue bonding/welding
Masimo, the inventor of Read-Through Motion & Low Perfusion Pulse Oximetry, has announced the next development in the world of noninvasive patient monitoring: Masimo Rainbow SET Pulse CO-Oximetry.
Ortho-Clinical Diagnostics, a Johnson & Johnson company, has announced the commercial availability of the Vitros 350 Chemistry System.
International Medical Innovations (IMI) announced that it has filed a new patent application with the U.S. Patent and Trademark Office related to a new format of PREVU Skin Sterol Test.
Protein Polymer Technologies has announced the successful development of a new surgical sealant designed to prevent air and fluid leaks following lung, gastrointestinal and cardiovascular surgery.
The U.S. launch of Johnson & Johnson's (J&J) artificial spinal disc has been hampered by insurance reimbursement issues.
Researchers at Oregon Health & Science University's Advanced Imaging Research Center (AIRC) are developing a new imaging method that may provide a clearer diagnosis of breast cancer.
PTC, the Product Development Company, announced the general availability of the PTC Medical Device Template, combining leading, industry specific capability and consulting expertise.
Palomar Medical Technologies announced the VisiLux1064 Laser Handpiece and the LuxIR Infrared Handpiece for the Palomar StarLux Pulsed Light and Laser System, and the DermaType Skinphotometer, presented at the American Academy of Dermatology's 63rd Annual Meeting in New Orleans.
Atherotech, a maker of cardiodiagnostic technology, announced that it has received $7.5 million in financing from ORIX Venture Finance.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.